-
Welcome to the WDWMAGIC.COM Forums!
Please take a look around, and feel free to sign up and join the community.
Covid Vaccine Updates and General Discussion About Vaccines
- Thread starter GoofGoof
- Start date
DisneyFan32
Well-Known Member
- In the Parks
- Yes
...A fall spike by October or November? Is really is not gonna happen? Noooo!Nah...you really don’t. Are we talking about the same great adventure??
Here’s the depressing news of the day:
So we’ll have enough open supply by May for adults in the US...there will be open access by June or no later than July...
...but the infectious disease experts are saying there’s enough vaccine hesitancy to NOT achieve herd immunity by September...insuring a fall spike.
People following idiots posing as “public officials”
You want to compare it to the flu? Good news...you made it one.
Difference is the flu vaccines are 50% less effective.
Give grandma a kiss for me
Yeah...I don’t think you’re gonna penetrate those shields, Captain Kirk.
ToTBellHop
Well-Known Member
Exciting real-world data reported on CNN:
The pharmaceutical companies Pfizer and BioNTech announced on Thursday morning that real-world evidence from the Israel Ministry of Health show that there have been "dramatically" fewer Covid-19 cases and deaths among people in Israel who have been fully vaccinated with the Pfizer/BioNTech vaccine compared with those who have been not vaccinated.
The latest analysis from the Israel Ministry of Health is based on data collected between Jan. 17 and March 6, according to the announcement. During that time, the Pfizer/BioNTech vaccine was the only Covid-19 vaccine available in the country and the coronavirus variant B.1.1.7, which was first identified in the United Kingdom, was dominant.
According to Pfizer and BioNTech's announcement, the latest analysis from the Israel Ministry of Health shows that two weeks after the second dose, vaccine effectiveness was at least 97% in preventing symptomatic disease, hospitalizations and death. The analysis also found that the vaccine effectiveness was 94% in preventing asymptomatic Covid-19, where infections show no symptoms
"We are extremely encouraged that the real-world effectiveness data coming from Israel are confirming the high efficacy demonstrated in our Phase 3 clinical trial and showing the significant impact of the vaccine in preventing severe disease and deaths due to COVID-19," Luis Jodar, senior vice president and chief medical officer at Pfizer Vaccines, said in the announcement.
The announcement comes about two weeks after a study published in the New England Journal of Medicine finding that the risk of symptomatic Covid-19 – meaning people who were infected with the coronavirus and felt sick – decreased by 94% among those who received two doses of the vaccine. Even before the second dose, the vaccine's effectiveness approached 60%.
"This clearly demonstrates the power of the COVID-19 vaccine to fight this virus and encourages us to continue even more intensively with our vaccination campaign. We aim to achieve even higher uptake in people of all ages, which gives us hope of regaining normal economic and social function in the not so distant future," Yeheskel Levy, Israel Ministry of Health director, said in the announcement.
"When we started our development last year in January, our aim was to make a difference for people worldwide and to help end this pandemic," Dr. Ugur Sahin, co-founder and CEO of BioNTech, said in the announcement. "One year after the declaration of a pandemic by the WHO, we now see that we are on the right track to accomplish our goals."
Albert Bourla, CEO of Pfizer, said data from Israel that shows the Pfizer/BioNTech vaccine prevents asymptomatic infection and death is a message of hope one year on from the declaration of a pandemic.
“It is a great opportunity, I think, that in this day of the first anniversary of the declaration of a pandemic, we do have a message of hope,” Bourla told CNBC’s Meg Tirrell on Squawk Box.
Bourla explained that the data comes from a country where more than 55% of the total population has been vaccinated.
Efficacy so far in Israel is at 97%, saying “all three measures, mild disease, hospitalizations and deaths are north of 97% in real world efficacy with millions of people vaccinated.”
Perhaps most important of all, he said, it appeared to be 94% effective against asymptomatic transmission.
Bourla said that this is important for society, “because the asymptomatic carriers, the asymptomatic patients are the ones that they are spreading the disease mainly.”
The pharmaceutical companies Pfizer and BioNTech announced on Thursday morning that real-world evidence from the Israel Ministry of Health show that there have been "dramatically" fewer Covid-19 cases and deaths among people in Israel who have been fully vaccinated with the Pfizer/BioNTech vaccine compared with those who have been not vaccinated.
The latest analysis from the Israel Ministry of Health is based on data collected between Jan. 17 and March 6, according to the announcement. During that time, the Pfizer/BioNTech vaccine was the only Covid-19 vaccine available in the country and the coronavirus variant B.1.1.7, which was first identified in the United Kingdom, was dominant.
According to Pfizer and BioNTech's announcement, the latest analysis from the Israel Ministry of Health shows that two weeks after the second dose, vaccine effectiveness was at least 97% in preventing symptomatic disease, hospitalizations and death. The analysis also found that the vaccine effectiveness was 94% in preventing asymptomatic Covid-19, where infections show no symptoms
"We are extremely encouraged that the real-world effectiveness data coming from Israel are confirming the high efficacy demonstrated in our Phase 3 clinical trial and showing the significant impact of the vaccine in preventing severe disease and deaths due to COVID-19," Luis Jodar, senior vice president and chief medical officer at Pfizer Vaccines, said in the announcement.
SARS-CoV-2 is the name of the virus that causes Covid-19.
The announcement comes about two weeks after a study published in the New England Journal of Medicine finding that the risk of symptomatic Covid-19 – meaning people who were infected with the coronavirus and felt sick – decreased by 94% among those who received two doses of the vaccine. Even before the second dose, the vaccine's effectiveness approached 60%.
"This clearly demonstrates the power of the COVID-19 vaccine to fight this virus and encourages us to continue even more intensively with our vaccination campaign. We aim to achieve even higher uptake in people of all ages, which gives us hope of regaining normal economic and social function in the not so distant future," Yeheskel Levy, Israel Ministry of Health director, said in the announcement.
"When we started our development last year in January, our aim was to make a difference for people worldwide and to help end this pandemic," Dr. Ugur Sahin, co-founder and CEO of BioNTech, said in the announcement. "One year after the declaration of a pandemic by the WHO, we now see that we are on the right track to accomplish our goals."
Albert Bourla, CEO of Pfizer, said data from Israel that shows the Pfizer/BioNTech vaccine prevents asymptomatic infection and death is a message of hope one year on from the declaration of a pandemic.
“It is a great opportunity, I think, that in this day of the first anniversary of the declaration of a pandemic, we do have a message of hope,” Bourla told CNBC’s Meg Tirrell on Squawk Box.
Bourla explained that the data comes from a country where more than 55% of the total population has been vaccinated.
Efficacy so far in Israel is at 97%, saying “all three measures, mild disease, hospitalizations and deaths are north of 97% in real world efficacy with millions of people vaccinated.”
Perhaps most important of all, he said, it appeared to be 94% effective against asymptomatic transmission.
Bourla said that this is important for society, “because the asymptomatic carriers, the asymptomatic patients are the ones that they are spreading the disease mainly.”
Sirwalterraleigh
Premium Member
DisneyFan32
Well-Known Member
- In the Parks
- Yes
So is Fall Spike is not gonna happen by October or November.
ToTBellHop
Well-Known Member
I don’t think that’s it. There seems to be a language barrier.
danlb_2000
Premium Member
I have discussed this with a few people, I don't think it's language.
ToTBellHop
Well-Known Member
Well, yes. That’s the other option.
ToTBellHop
Well-Known Member
Certainly more likely than not to be correct, but like Big Brother (is that still on TV?), “expect the unexpected.”
Sirwalterraleigh
Premium Member
Sirwalterraleigh
Premium Member
The conditions may be present. Which is kinda what they’ve said every step of the way and they’ve had a “hot hand” at the table
danlb_2000
Premium Member
Seems like a pretty bold statement. I could see possibly eradicating it in the US, but I don't see that happening globally by then, and as long as it's circulating somewhere it is still a threat to everyone.
GimpYancIent
Well-Known Member
I see sitting back enjoying a few beers and watching events unfold while staying out of the way. I see things unfolding rather quickly with good results even though everyone is not at the same speed.
ToTBellHop
Well-Known Member
But we are America. We ignore illnesses endemic elsewhere. We will be busy having Roaring ‘20s themed NYE parties. We won’t wear masks because of a virus in India and Chile. We will probably continue to be very selective in allowable international travel. We have spent the better part of a year with significant limitations on domestic travel that are only now being loosened. I would expect international travel to take much longer to open up, probably starting with Europe later this year (UK sooner, I’d imagine, since it’s easy to do due to their vaccination pace and Brexit).
Last edited:
Queen of the WDW Scene
Well-Known Member
- In the Parks
- No
My guess is disability which is why I'm now choosing to leave well enough alone.
Yes, it’s very possible. Disney will follow CDC and public health experts. If they relax the recommendations for masks and places like MLB stadiums and concerts and other places where large groups gather stop requiring them I could see Disney following. They won’t be a first mover but I don’t see the, keeping masks for no good reason. A lot depends on case numbers nationally as well as studies on vaccines.
So far the vaccine news is really great as they look like they are very highly effective at both stopping symptoms as well as stopping infection and spread. So if people who are vaccinated really can’t spread covid that means they really don’t need a mask. Once the vast majority are vaccinated (say 80%) do we make 100% of people wear masks indefinitely so that the 20% that are unvaccinated are less likely to infect each other? It becomes a very easy answer IMHO if/when community spread is way down and a large percentage of adults is vaccinated.
So I officially joined the ranks of the partially vaccinated today. Got the Moderna shot. So far no issues. It’s been a long time coming and it feels really good to finally get there. I won’t be fully satisfied until the rest of my family is covered but it’s a start. 28 days until shot 2 and then 2 weeks after for full effect.
Sirwalterraleigh
Premium Member
Very unlikely the mask mandates are dropped this year...things would have to go “perfectly” to get everything that low...and nature is far from perfect.
We may get to a point where there’s no “danger” in dropping it...but liability is still the key. They won’t risk removing policies prematurely...and status quo is the default in near all operational decisions.
Too optimistic at this point.
Good to hear... I cleared the Pfizer sequence a few days ago (5 weeks)
I think it’s too early to say. We just don’t know what public sentiment will be. I really think a large number of people will strongly object to Covid restrictions months after the danger has passed. Disney won’t keep restrictions longer than they have to.